These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 3936095)
1. The effects of nicotinic acid and xanthinol nicotinate on human memory in different categories of age. A double blind study. Loriaux SM; Deijen JB; Orlebeke JF; De Swart JH Psychopharmacology (Berl); 1985; 87(4):390-5. PubMed ID: 3936095 [TBL] [Abstract][Full Text] [Related]
2. Comparative effects of placebo and plain and slow-release tablets of xanthinol nicotinate on exercise tolerance in normal human subjects. Sharma PL Int J Clin Pharmacol Biopharm; 1978 Jan; 16(1):19-21. PubMed ID: 631966 [TBL] [Abstract][Full Text] [Related]
3. Xanthinol nicotinate in the management of leg ulcers associated with haemoglobinopathies. Afifi AM; Adnan M; Taha M; Amasha ME Curr Med Res Opin; 1979; 6(5):309-13. PubMed ID: 540521 [TBL] [Abstract][Full Text] [Related]
4. [Bioavailability and tolerance of xanthinol nicotinate depot preparations. Comparison of a conventional 500 mg xanthinol nicotinate depot tablet with new 500 mg and 1 g depot tablets]. von Schrader HW; Buscher G; Dierdorf D; Freytag A; Mügge H; Wolf D Arzneimittelforschung; 1985; 35(9):1468-72. PubMed ID: 4084347 [TBL] [Abstract][Full Text] [Related]
5. Effect of xanthinol nicotinate treatment on platelet aggregation. Seidel G; Endell W Int J Clin Pharmacol Biopharm; 1977 Mar; 15(3):139-43. PubMed ID: 844933 [TBL] [Abstract][Full Text] [Related]
6. [The influence of xanthinol nicotinate and of a hyperosmolar solution on the motility of the colon]. Willmen HR; Kogel H Int J Clin Pharmacol Biopharm; 1976 Mar; 13(2):133-8. PubMed ID: 1254378 [TBL] [Abstract][Full Text] [Related]
7. [Effect of pentoxifylline, xanthinol nicotinate and theophylline on the cardiovascular system, myocardial dynamics and left ventricular contractility of the dog in short-system, experiments]. Komarek J; Cartheuser C Arzneimittelforschung; 1977; 27(10):1932-9. PubMed ID: 579103 [No Abstract] [Full Text] [Related]
8. Effect of beta1-24-corticotropic hormone, angiotensin II and xanthinol nicotinate on the kinetics of aldosterone. Pinsker P; Bultasová H; Bláha V; Vavrejn B Rev Czech Med; 1977; 23(4):206-13. PubMed ID: 201974 [No Abstract] [Full Text] [Related]
9. [Effect of lipid-lowering treatment with xanthinol-nicotinate on the carbohydrate metabolism in mature-onset diabetics and non-diabetic patients with hyperlipoproteinemias (HLP)]. Haacke H; Parwaresch MR; Rube O; Mäder C Verh Dtsch Ges Inn Med; 1978; (84):1157-60. PubMed ID: 741915 [No Abstract] [Full Text] [Related]
10. [The effect of the beta1-24 corticotropic hormone, angiotensin II and xanthinol nicotinate on the kinetics of aldosterone (author's transl)]. Pinsker P; Bultasová H; Bláha V; Vavrejn B Cas Lek Cesk; 1977 Jan; 116(2):35-8. PubMed ID: 191194 [No Abstract] [Full Text] [Related]
11. [Various trials on the effect of nicotinic acid and Complamin on fibrinolysis]. MOERS AM; den OTTOLANDER GJ Ned Tijdschr Geneeskd; 1962 Jun; 106():1221-5. PubMed ID: 14475011 [No Abstract] [Full Text] [Related]
12. Pharmacological evaluation of xanthinol nicotinate (complamin). Galal E; Moustafa M; el-Gohary N; el-Mahdy SA; el-S Ali HI; Radwan AG J Egypt Med Assoc; 1976; 59(1-2):141-9. PubMed ID: 1032367 [No Abstract] [Full Text] [Related]
13. [TREATMENT OF HYPERCHOLESTEREMIA WITH COMPLAMIN (7-/2-HYDROXY-3-(N-2-HYDROXYETHYL-N-METHYLAMINO)-PROPYLTHEOPHYLLINE NICOTINATE)]. BRANDEL E Z Gesamte Inn Med; 1965 May; 20():283-7. PubMed ID: 14306484 [No Abstract] [Full Text] [Related]
14. [ON THE TREATMENT OF APOPLEXY WITH COMPLAMIN (7-(2-HYDROXY-3-(N-2-HYDROXYETHYL-N-METHYLAMINO)PROPYL)THEOPHYLLINE NICOTINATE]. FRUHMANN H Med Welt; 1963 Oct; 41():2084-7. PubMed ID: 14134155 [No Abstract] [Full Text] [Related]
15. Acute effect of xanthinol nicotinate on the muscle clearance of 133Xenon. Szilvási I; Molnár G Ther Hung; 1973; 21(3-4):114-6. PubMed ID: 4806418 [No Abstract] [Full Text] [Related]
16. [Effect of xanthinol nicotinate on brain metabolism in rats]. Brenner G Arzneimittelforschung; 1983; 33(5):698-701. PubMed ID: 6683547 [TBL] [Abstract][Full Text] [Related]
17. [Pharmacological properties and clinical use of xanthinol nicotinate]. Mashkovskiĭ MD; Iuzhakov SD; Absava GI; Erokhina LG; Lebedeva NV Klin Med (Mosk); 1984 Nov; 62(11):30-4. PubMed ID: 6097742 [No Abstract] [Full Text] [Related]
18. [Results of a long-term study on the therapeutic effectiveness of xanthinol nicotinate in chronic hepatopathies]. Dohrmann RE; Kessel ME Z Allgemeinmed; 1975 Sep; (26):1167-72. PubMed ID: 1226797 [No Abstract] [Full Text] [Related]
19. [Comparative evaluation of the wound-healing effect of benzofuracaine, etaden, and xanthinol nicotinate in an experiment]. Stepaniuk GI; Ornostaĭ VV; Kozlov VG Patol Fiziol Eksp Ter; 1992; (3):16-8. PubMed ID: 1480413 [TBL] [Abstract][Full Text] [Related]
20. [Effect of pentoxyfylline and xanthinol nicotinate on the overall blood pressure and tonus of cerebral and peripheral vessels]. Gaevyĭ MD; Sankina TV; Nagornaia GV Farmakol Toksikol; 1984; 47(1):53-7. PubMed ID: 6705904 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]